Drug interactions
Brexucabtagene autoleucel + Cisplatin
Severity: Moderate
Brexucabtagene autoleucel and Cisplatin: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Cisplatin causes myelosuppression and lymphopenia, which can impair CAR T-cell expansion and add to infection risk. Chemotherapy near CAR T infusion, other than planned lymphodepletion, may compromise efficacy and safety.
What this interaction means in plain words
Brexucabtagene autoleucel and Cisplatin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Brexucabtagene autoleucel belongs to Oncology; Cisplatin belongs to Oncology.
Why it happens
Additive myelosuppressive and lymphotoxic effects may reduce CAR T-cell persistence and increase infection risk.
What to do
Avoid cisplatin around leukapheresis and CAR T infusion unless part of planned bridging. Monitor blood counts and infection signs.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Brexucabtagene autoleucel and Cisplatin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Cisplatin
- Cidofovir + Cisplatin Contraindicated
- Adefovir + Cisplatin Major
- Adenovirus types 4 and 7 live + Cisplatin Major
- Amikacin + Cisplatin Major
- Amphotericin b deoxycholate + Cisplatin Major
- Amphotericin b + Cisplatin Major
Other interactions of Brexucabtagene autoleucel
Frequently asked questions
Can I take Brexucabtagene autoleucel with Cisplatin?
MediHelp rates the interaction as moderate. Brexucabtagene autoleucel and Cisplatin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Cisplatin causes myelosuppression and lymphopenia, which can impair CAR T-cell expansion and add to infection risk. Chemotherapy near CAR T infusion, other than planned lymphodepletion, may compromise efficacy and safety.
How serious is the interaction between Brexucabtagene autoleucel and Cisplatin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid cisplatin around leukapheresis and CAR T infusion unless part of planned bridging. Monitor blood counts and infection signs.
What other medicines interact with Cisplatin?
MediHelp also lists interactions of Cisplatin with, for example, Cidofovir, Adefovir, Adenovirus types 4 and 7 live. The full list is on the Cisplatin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
